Immatics Cash from 2010 to 2024
| IMTXW Stock | USD 0.40 0.06 13.04% |
Cash | First Reported 2019-03-31 | Previous Quarter 158.1 M | Current Value 189.2 M | Quarterly Volatility 70.7 M |
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.7 M or Interest Income of 14.5 M, as well as many indicators such as Price To Sales Ratio of 13.5, Dividend Yield of 0.0 or PTB Ratio of 3.58. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
Immatics | Cash |
Latest Immatics Biotechnologies' Cash Growth Pattern
Below is the plot of the Cash of immatics biotechnologies GmbH over the last few years. Cash refers to the most liquid asset of Immatics Biotechnologies, which is listed under current asset account on immatics biotechnologies GmbH balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Immatics Biotechnologies customers. The amounts must be unrestricted with restricted cash listed in a different Immatics Biotechnologies account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Immatics Biotechnologies' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Immatics Cash Regression Statistics
| Arithmetic Mean | 127,962,397 | |
| Geometric Mean | 122,964,467 | |
| Coefficient Of Variation | 32.07 | |
| Mean Deviation | 32,812,530 | |
| Median | 103,353,000 | |
| Standard Deviation | 41,031,475 | |
| Sample Variance | 1683.6T | |
| Range | 115.1M | |
| R-Value | 0.73 | |
| Mean Square Error | 849.4T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | 6,688,945 | |
| Total Sum of Squares | 23570.1T |
Immatics Cash History
Other Fundumenentals of Immatics Biotechnologies
Immatics Biotechnologies Cash component correlations
Click cells to compare fundamentals
About Immatics Biotechnologies Financial Statements
Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 218.5 M | 178.4 M | |
| Cash And Short Term Investments | 425.9 M | 282.6 M | |
| Change In Cash | 70 M | 73.5 M | |
| Free Cash Flow | -12.7 M | -12.1 M | |
| Begin Period Cash Flow | 148.5 M | 117.4 M | |
| Other Cashflows From Financing Activities | -2 M | -2.1 M | |
| Other Non Cash Items | -13 M | -12.4 M | |
| Total Cash From Operating Activities | 18.2 M | 19.1 M | |
| Total Cash From Financing Activities | 84.5 M | 79.8 M | |
| End Period Cash Flow | 218.5 M | 155.9 M | |
| Free Cash Flow Yield | (0.02) | (0.02) | |
| Operating Cash Flow Per Share | 0.23 | 0.24 | |
| Free Cash Flow Per Share | (0.16) | (0.17) | |
| Cash Per Share | 5.29 | 2.74 | |
| Capex To Operating Cash Flow | 1.70 | 1.78 | |
| EV To Operating Cash Flow | 30.96 | 32.50 | |
| EV To Free Cash Flow | (44.33) | (42.11) | |
| Price To Operating Cash Flows Ratio | 42.10 | 44.20 | |
| Price To Free Cash Flows Ratio | (60.28) | (57.27) | |
| Cash Ratio | 1.40 | 1.94 | |
| Cash Conversion Cycle | 15.20 | 14.44 | |
| Operating Cash Flow Sales Ratio | 0.34 | 0.32 | |
| Free Cash Flow Operating Cash Flow Ratio | (0.70) | (0.66) | |
| Cash Flow Coverage Ratios | 4.57 | 4.06 | |
| Price Cash Flow Ratio | 42.10 | 44.20 | |
| Cash Flow To Debt Ratio | 4.57 | 4.06 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immatics Stock Analysis
When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.